MGN3 Improves Efficacy of Chemotherapy Drug

MGN3 Improves Efficacy of Chemotherapy Drug

ALLENDALE, N.J.A recent study conducted at Drew University ofMedicine and Science in Los Angeles indicated MGN3, a patented formula of ricebran hydrolyzed with Shiitake mushroom extracts, can increase the efficacy ofchemotherapy against certain cancer cells, according to LaneLabs (www.lanelabs.com),which markets the compound. In vitro testing showed that adriamycin (achemotherapy drug) induced apoptosis at doses of 25 mg in multi-drugresistanttumor cells. When MGN3 was added to the treatment, only 7 mg to 8 mg ofadriamycin were necessary to achieve the same results. Based on these in vitroresults, LaneLabs plans to clinically test MGN3 in humans undergoingchemotherapy.